Board meeting held on March 26, 2025
As filed · GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on March 26, 2025.
What happened
FactGlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on March 26, 2025. Outcome of Board Meeting. 2025, for a period of first term of five (5) consecutive years, not liable to retire by rotation,.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Demand
RevisedOur volume growth was about 3%, 3.5% for the quarter and that's a blended across the entire business.
For the first time, we also have new introductions. So you just heard me and Ron talk about 7% of our contribution now coming from the innovation portfolio.
Change
FactImplication
CapitSignal interpretationDemand
RevisedFor the first time, we also have new introductions. So you just heard me and Ron talk about 7% of our contribution now coming from the innovation portfolio.
Shingrix has grown by 65% -- so that should tell you it's been a good blend of both price, volume and so it's value, volume and new introductions for us.
Change
FactImplication
CapitSignal interpretationDemand
RevisedShingrix has grown by 65% -- so that should tell you it's been a good blend of both price, volume and so it's value, volume and new introductions for us.
3%, 3.5% on volumes, about 6% on price; the balance is all new introductions.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- I think in the next two or three months, hopefully within this financial year or the first quarter of next yea (management committed by Q1 FY27)
Evidence
- GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about change in Management(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%